Profile photo Fariba Ahmadizar

Fariba Ahmadizar

Assistant Professor

Strategic program(s):

Biography

Fariba Ahmadizar, PharmD, MSc and PhD in Epidemiology, is a senior Assistant Professor at the Data Science and Biostatistics Department, now visiting scholar at the Epidemiology Department, Harvard School of Public Health, Boston, USA. 

Research and Academic Contributions: Fariba interest is in biomarker discovery in cardiometabolic disorders, focusing on the intersection of omics (e.g., genetics and metabolomics), risk factors, drug response, and public health. 
Fariba is a Principal Investigator leading various initiatives and consortia, demonstrating her commitment to advancing research and education. She is currently the Principal Investigator of the observational Post-Authorization Safety Study for the Janssen COVID-19 vaccine. Her significant contributions extend to numerous fellowships, grants, and supervision of postdocs, Ph.D., and MSc students.

Farib actively contributes to the scientific community by organizing and coordinating pre-conference courses, serving as an international scientific coordinator, and holding editorial roles in reputable journals. Her extensive reviewing activities for renowned journals reflect her dedication to maintaining high research standards.
Contact me via e-mail if you would like to reach out:
f.ahmadizar@umcutrecht.nl

Research groups

Real World Evidence group

Research aim

The Real-World Evidence group at the University Medical Center Utrecht has the vision that we should generate best evidence from real world data in a learning health care system.

Go to group

Recent publications

Association between gut microbiome profiles and host metabolic health across the life course Ruolin Li, Alexander Kurilshikov, Shuyue Yang, Julie A.E. van Oortmerssen, Arno van Hilten, Fariba Ahmadizar, Gennady Roshchupkin, Robert Kraaij, Liesbeth Duijts, Jingyuan Fu, M. Kamran Ikram, Vincent W.V. Jaddoe, André G. Uitterlinden, Fernando Rivadeneira, Maryam Kavousi, Alexandra Zhernakova, Carolina Medina-Gomez
The Lancet Regional Health - Europe, 2025, vol. 50
Machine learning-based models to predict the conversion of normal blood pressure to hypertension within 5-year follow-up Aref Andishgar, Sina Bazmi, Reza Tabrizi, Maziyar Rismani, Omid Keshavarzian, Babak Pezeshki, Fariba Ahmadizar
PLoS ONE, 2024, vol. 19
Metabolic syndrome, radiographic osteoarthritis progression and chronic pain of the knee among men and women from the general population I A Szilagyi, N L Nguyen, C G Boer, D Schiphof, F Ahmadizar, M Kavousi, S M A Bierma-Zeinstra, J B J van Meurs
Seminars in Arthritis and Rheumatism, 2024, vol. 69, p.152544
Subclassification of obesity for precision prediction of cardiometabolic diseases Daniel E Coral, Femke Smit, Ali Farzaneh, Alexander Gieswinkel, Juan Fernandez Tajes, Thomas Sparsø, Carl Delfin, Pierre Bauvain, Kan Wang, Marinella Temprosa, Diederik De Cock, Jordi Blanch, José Manuel Fernández-Real, Rafael Ramos, M Kamran Ikram, Maria F Gomez, Maryam Kavousi, Marina Panova-Noeva, Philipp S Wild, Carla van der Kallen, Michiel Adriaens, Marleen van Greevenbroek, Ilja Arts, Carel Le Roux, Fariba Ahmadizar, Timothy M Frayling, Giuseppe N Giordano, Ewan R Pearson, Paul W Franks
Nature medicine, 2024, vol. 31, p.534–543
Author Correction Daniel E. Coral, Femke Smit, Ali Farzaneh, Alexander Gieswinkel, Juan Fernandez Tajes, Thomas Sparsø, Carl Delfin, Pierre Bauvin, Kan Wang, Marinella Temprosa, Diederik De Cock, Jordi Blanch, José Manuel Fernández-Real, Rafael Ramos, M. Kamran Ikram, Maria F. Gomez, Maryam Kavousi, Marina Panova-Noeva, Philipp S. Wild, Carla van der Kallen, Michiel Adriaens, Marleen van Greevenbroek, Ilja Arts, Carel Le Roux, Fariba Ahmadizar, Timothy M. Frayling, Giuseppe N. Giordano, Ewan R. Pearson, Paul W. Franks
Nature medicine, 2024, vol. 31
Statin therapy and cardiovascular protection in type 2 diabetes Negin Soroush, Mitra Nekouei Shahraki, Soroush Mohammadi Jouabadi, Masoud Amiri, Elif Aribas, Bruno H Stricker, Fariba Ahmadizar
NMCD : Nutrition metabolism and cardiovascular diseases, 2024, vol. 34, p.2021-2033